+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

2019 Cystoid Macular Edema Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 132 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767555
UP TO OFF until Jan 05th 2023
The global clinical trial report- “2019 Cystoid Macular Edema Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Cystoid Macular Edema. It presents in-depth analysis of Cystoid Macular Edema clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cystoid Macular Edema.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Cystoid Macular Edema clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Cystoid Macular Edema

The research work is prepared through extensive and continuous research on Cystoid Macular Edema trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Cystoid Macular Edema patients are identified

  • The report includes panorama of Cystoid Macular Edema clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Cystoid Macular Edema clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Cystoid Macular Edema Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Cystoid Macular Edema Clinical Trials by Region
2.2.2 Average Enrollment of Cystoid Macular Edema Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Cystoid Macular Edema Treatment, 2019
3. Region wise Cystoid Macular Edema Clinical Trials
3.1 Asia Pacific Cystoid Macular Edema Clinical Trials by Country
3.2 Europe Cystoid Macular Edema Clinical Trials by Country
3.3 North America Cystoid Macular Edema Clinical Trials by Country
3.4 Middle East and Africa Cystoid Macular Edema Clinical Trials by Country
3.5 South and Central America Cystoid Macular Edema Clinical Trials by Country
4. Cystoid Macular Edema Clinical Trial Trends
4.1 Start Year wise Cystoid Macular Edema Clinical Trials
4.2 Phase wise Cystoid Macular Edema Clinical Trials
4.3 Trial Status wise Cystoid Macular Edema Clinical Trials
4.4 Trial Type wise Cystoid Macular Edema Clinical Trials
5. Cystoid Macular Edema Average Enrollment Trends
5.1 Average Enrollment in Cystoid Macular Edema Trials by Year
5.2 Average Enrollment in Cystoid Macular Edema Trials by Phase
5.3 Average Enrollment in Cystoid Macular Edema Trials by Status
5.4 Average Enrollment in Cystoid Macular Edema Trials by Type of Trial
6. Companies Participating in Cystoid Macular Edema Clinical Trials
6.1 Cystoid Macular Edema Trials by Sponsor Type
6.2 Cystoid Macular Edema Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Cystoid Macular Edema Trials- Phase 1
7.2 Cystoid Macular Edema Trials- Phase 2
7.3 Cystoid Macular Edema Trials- Phase 3
7.4 Cystoid Macular Edema Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Cystoid Macular Edema Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Figure 5: Europe - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Figure 7: North America - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Figure 9: Cystoid Macular Edema Clinical Trials by Phase
Figure 10: Cystoid Macular Edema Clinical Trials by Trial Status
Figure 11: Cystoid Macular Edema Clinical Trials by Type
Figure 12: Cystoid Macular Edema Clinical Trials by Sponsor Type
Figure 13: Cystoid Macular Edema Clinical Trials by Leading Sponsors
Figure 14: Cystoid Macular Edema Average Enrollment by Phase
Figure 15: Cystoid Macular Edema Average Enrollment by Trial Status
Figure 16: Cystoid Macular Edema Average Enrollment by Type
Figure 17: Cystoid Macular Edema- Average Enrolment by Type of Sponsors
Figure 18: Cystoid Macular Edema- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Cystoid Macular Edema Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Table 5: Europe - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Table 7: North America - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Cystoid Macular Edema Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Cystoid Macular Edema Average Enrollment by Phase
Table 15: Cystoid Macular Edema Average Enrollment by Trial Status
Table 16: Cystoid Macular Edema Average Enrollment by Type
Table 17: Cystoid Macular Edema- Average Enrolment by Type of Sponsors
Table 18: Cystoid Macular Edema- Enrolment by Leading Sponsors

Companies Mentioned

  • Allergan Plc

  • Bayer AG

  • Bp Consulting Inc

  • Dompe Farmaceutici SpA

  • EyeGate Pharmaceuticals Inc

  • F. Hoffmann-La Roche Ltd

  • Icon Bioscience Inc

  • Merck & Co Inc

  • Oldtech Inc

  • Valeant Pharmaceuticals International Inc